Abstinence |
|
|
Clinical Trial: Evaluation of Abstinence-Only and Abstinence-Plus Programs to Prevent HIV, STD, and Pregnancy Among Middle School Students
This study is not yet open for patient recruitment.
Verified by Centers for Disease Control and Prevention September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| HIV Sexually Transmitted Diseases Pregnancy | Behavior: Sexual risk avoidance intervention Behavior: Sexual risk reduction intervention Behavior: Usual care school-based sexual eduction | Phase II |
MedlinePlus related topics: Sexually Transmitted Diseases
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Secondary Outcomes: Secondary hypotheses will examine the effect of the Students’ knowledge, self-efficacy, refusal skills, attitudes,
Expected Total Enrollment: 2000
Study start: October 2005; Expected completion: September 2009
Last follow-up: July 2009; Data entry closure: July 2009
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- For Phase I, approximately 80 7th and 8th grade students will be recruited from regular classes in HISD middle schools (e.g. Health Education, Physical Education, English, or Science) to participate in focus groups. During recruitment, students will be informed that focus groups will be conducted in English. Students will be asked to consider their level of comfort with participating in an English-only focus group prior to agreeing to participate. Approximately 80 parents of 7th and 8th grade students will also be recruited from schools and community organizations to participate in focus groups. Additionally, approximately 12-15 HISD personnel will be contacted through previously identified school contacts and invited to participate in interviews.
For Phase II, 7th and 8th grade students will be recruited from regular classes in 4-6 HISD middle schools to participate in pilot testing of the survey and intervention. Students will be informed that the survey and intervention materials will only be pilot tested in English and asked to consider their comfort level with participating in an English-only pilot test prior to agreeing to participate.
For Phase III, HISD middle schools serving predominantly minority youth will be invited to participate in the main evaluation study. Of these, 15 schools will be randomized to intervention and comparison conditions. Approximately 1500 7th grade students will be recruited into the study with approximately equal representation of male and female students. Students will be recruited through regular classes until the minimum sample size is obtained (approximately 100 students per school). Students will be informed that the surveys and intervention materials will only be available in English and asked to consider their comfort level with participating in the study.
Exclusion Criteria:
- No students in the 7th and 8th grade will be excluded based on race/ethnicity, age, or gender. For all phases of the study, individuals of other race/ethnicities (e.g. Non-Hispanic Whites, Asian, and Native American) that express interest and/or agree to participate will not be excluded. For all Phases, students will be recruited from regular classes in HISD middle schools (e.g. Health Education, Physical Education, English, or Science). Students will be informed that the surveys and intervention materials will only be available in English and will be asked to consider their comfort level with participating in the study. However, we anticipate that the majority of students will be fluent in English and able to participate in the study. For Phase I, both mothers and fathers whose 7th and 8th graders live with them most of the time will be recruited to participate in the parent focus groups. However, we anticipate that the majority of these participants will be mothers.
Location and Contact Information
Texas
Center for Health Promotion and Prevention Research, University of Texas, Houston, Houston, Texas, 77030, United States
Christine Markham, PhD, Principal Investigator
Leah E Robin, PhD, Study Chair, Centers for Disease Control and Prevention
Christine Markham, PhD, Principal Investigator, University of Texas, Houston
More Information
Last Updated: September 20, 2005
Record first received: September 13, 2005
ClinicalTrials.gov Identifier: NCT00207545
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-27

Not Signed In -


